Delivery Order SPE2DB20D3111-SPE2DB25FA8RY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,433.30 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,819.43. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a contract value of $1,913.34. This non-competitive, firm fixed-price delivery order was awarded on May 2, 2025, with an ultimate completion date of May 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,929.35 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg in quantities of 100 capsules. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100-count) with a ceiling value of $1,202.32. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 7, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.00 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count). The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed this delivery order under firm fixed price terms. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count bottles) with a contract ceiling value of $1,772.16. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8RYDelivery Order
The Defense Logistics Agency awarded a $1,048.50 delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for the stimulant medication reflects the company's ongoing role in fulfilling neurological and behavioral health treatment needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/29/25 |